Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
NPJ Digital Medicine|July 8, 2025
Digital transformation with clinical alerts and personalized care systems in an integrated value based modelDinh Nguyen, Sinjin Lee, Ronil Synghal, et al.
Journal of Extracellular Vesicles|February 9, 2026
Lipidomic Analysis of Plasma Extracellular Vesicles from Adiponectin Deficient Mice or Metabolic Syndrome Patients Reveals Pro-Oxidative and Pro-Inflammatory Lipid Signatures Correlating with Metabolic DysfunctionSungji Cho, Hye Kyoung Sung, Khang Nguyen, et al.
Advanced Healthcare Materials|April 14, 2026
Extracellular Vesicles Modulation by an Adiponectin Receptor Agonist Provides Cardioprotection for Myocardial Ischemic InjuryJialing Tang, Wing Yan Chung, Serena M Pulente, et al.
Cancers|April 14, 2026
Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective TreatmentIrina Zh Shubina, Chi-Bao Bui, Truc Ly Nguyen, et al.
ACS Omega|October 30, 2023
Extraction and Emulsification of Carotenoids from Carrot Pomaces Using Oleic AcidTan Phat Vo, Hoang Khanh Linh Tran, Thi Minh Ngoc Ta, et al.
Asia Pacific Allergy|April 10, 2026
Blended reactions and angioedema are common in patients with cross-reactive nonsteroidal anti-inflammatory drug hypersensitivityDuy Le Pham, Huy Duc Le, Diep Khang Nguyen, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2023
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLDBeom K Kim, Nicole Bernstein, Daniel Q Huang, et al.
Journal of Hepatology|August 16, 2022
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLDBeom Kyung Kim, Nobuharu Tamaki, Kento Imajo, et al.
Science Advances|June 19, 2026
Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAPNazli Robin, Nicole G Barra, Kevin P Foley, et al.
The Lancet. Oncology|May 14, 2021
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort studyInes Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
Pageof 9